Training and Support for Hybrid Closed-Loop Therapy
Year: 2020
Type: editorial
Abstract: Hybrid closed-loop therapy is an emerging technology transforming the management of type 1 diabetes (T1D). Research studies demonstrate glycemic and quality of life benefits of hybrid closed-loop therapy for people with T1D. Translating these outcomes into standard clinical practice is critical for reimbursement and improving access to this technology.High-quality training is essential for achieving optimal outcomes with hybrid closed-loop therapy. Basic diabetes skills and tasks are as important, or even more important, with closed-loop therapy than with standard insulin therapy and need to be reiterated. Establishing expectations of hybrid closed-loop therapy clearly at the outset promotes long-term usage and optimal outcomes.We share key aspects of training and support for users of commercially available hybrid closed-loop systems and consider who may benefit from this technology.
Authors: Charlotte K. Boughton, Sara Hartnell, Janet M. Allen, Julia Fuchs, Roman Hovorka
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
Funders: Leona M. and Harry B. Helmsley Charitable Trust, Wellcome Trust, National Institute for Health and Care Research, European Commission, Cambridge University Hospitals, Efficacy and Mechanism Evaluation Programme, NIHR Cambridge Biomedical Research Centre, NIHR Evaluation Trials and Studies Coordinating Centre
Awards: G10500178, G2018687014, G434337789, G461391184, Institute of Metabolic Science., G5246447471, Effect of closed loop insulin delivery from onset of diabetes in youth on progression of type 1 diabetes, G8585681489, G8589133502, G8758826526, The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
OpenAlex ID: W3083846587